Global Sleep Apnea Diagnostic And Therapeutic Market Trends 2019-2027

1
GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC
MARKET
FORECAST 2019-2027
2
(No Transcript)
3

• The disorder of sleep apnea occurs when a
  patients breathing patterns during sleep
  decreases or pauses momentarily (called apnea)
  for 10 seconds or longer and it can occur 30
  times or more in an hour.
• The global sleep apnea diagnostic and therapeutic
  market is anticipated to generate revenue of
  9,986 million by 2027 and will grow at an
  estimated CAGR of 6.72 between 2019 and 2027.
• Increase in the number of shift workers, the
  rising prevalence of sleep apnea and the
  technological advancements are mainly driving the
  market growth.

4

• Obesity is considered a major risk factor in the
  development and progression of sleep apnea.
• The prevalence of sleep apnea in obese patients
  is almost two-fold higher than the normal case.
  Some of the factors that are expected to
  contribute to the sleeping disorders in the
  elderly population are retirements, various
  cognitive problems, excessive daytime sleepiness,
  and many more.
• The medical devices are specialized equipment
  that requires government approval for their sale.
  Obtaining approval can be a time-consuming and
  high-cost procedure, which can affect market
  growth. The need for RD efforts and low heat
  resistance are the major factors hindering the
  sleep apnea diagnostic and therapeutic market.

5
(No Transcript)
6
The Global Sleep Apnea Diagnostic and
Therapeutic Market is estimated to grow at a CAGR
of 6.72 between 2019 and 2027.
7
The North America market for sleep apnea
diagnostic and therapeutic services are expected
to proliferate at a CAGR of 6.00 during the
forecasting years of 2019-2027.
8
The Europe Market for Sleep Apnea Diagnostic and
Therapeutic Market is proliferating at a CAGR of
6.15 during the forecasting years of 2019-2027.
9
The Asia Pacific Sleep Apnea Diagnostic and
Therapeutic Market is estimated to grow from xx
million in 2018 to xx million by 2027, at a CAGR
of 8.67 between 2019 and 2027.
10
The major market players operating in the market
are CareFusion (Merged With Becton Dickinson),
Koninklijke Philips N.V. (Philips), Resmed Inc.,
Nihon Kohden Corporation, Medtronic PLC, Smiths
Group PLC (Smiths Medical), Itamar Medical Ltd.,
Invacare Corp., Fisher Paykel Healthcare, Drive
Devilbiss Healthcare, Cadwell, GE Healthcare,
Teleflex, Braebon Medical Corporation and
Somnomedics. These market players follow several
key developmental strategies and focus on
launching innovative diagnosis products to cater
to patients as well as medical professionals
requirements and to strengthen their market share.
11
(No Transcript)
12
(No Transcript)
13
(No Transcript)